期刊文献+

依巴斯汀递减疗法和每日疗法治疗慢性荨麻疹疗效比较 被引量:11

The Comparison of the Curative Effect between Decreasing Treatment and Daily Treatment of Ebastine Used in Chronic Urticaria
下载PDF
导出
摘要 目的观察依巴斯汀递减疗法和每日疗法治疗慢性荨麻疹的疗效。方法将受试者随机分为2组,治疗组采用依巴斯汀递减疗法,对照组采用依巴斯汀每日疗法治疗,疗程均为4周。结果治疗组患者有效率为92.00%,停药4周后复发率为32.00%;对照组有效率为78.26%,停药4周后复发率为60.87%,两组有效率及复发率比较,差异均有统计学意义(P均<0.05)。结论依巴斯汀递减疗法治疗慢性荨麻疹较每日疗法的疗效好,且复发率低。 Objective To observe the curative effect of chronic urticaria in the decreasing treatment and daily treatment of Ebastine.Methods All the patients were randomly divided into decreasing treatment group (experimental group) and daily treatment group (control group).Results After 4 weeks of treatment it showed that in the experimental group of patients the effective rate was 92.00%,4 weeks after discontinuation the recurrent rate was 32.00%.The efficiency of the control group patients was 78.26%,4 weeks after discontinuation recurrent rate was 60.87%.There was significantly difference (P〈0.05) between the two groups about the effective and relapse rates.Conclusion Have a better efficacy and lowerer recurrent rate than daily treatrnent.
出处 《中国皮肤性病学杂志》 CAS 北大核心 2010年第4期393-394,共2页 The Chinese Journal of Dermatovenereology
关键词 慢性荨麻疹 递减疗法 依巴斯汀 Chronic urticaria Decreasing treatment Ebastine
  • 相关文献

参考文献4

二级参考文献39

  • 1[2]Hurst M, Spencer M. Ebastine: An update of its use in allergic disordes[J]. Drugs, 2000, 59(4): 981-1006.
  • 2[3]Kaplan AP. Clinical practice. Chronic urticaria and angioedema[J].N Engl J Med, 2002, 346(3): 175-179.
  • 3[4]Gispert J, Antonijoan R, Barbanoj M, et al. Efficacy of ebastine,cetirizine, and loratadine in histamine cutaneous challenges[J]. Ann Allergy Asthma Immunol, 2002, 89(3): 259-364.
  • 4[5]Malik M. Problems of heart rate correction in assessment of druginduced QT interval prolongation[J]. J Cardiovasc Electrophysiol,2001, 12(4): 411-420.
  • 5[6]Hindmarch I, Shamsi Z. Antihistamine: models to assess sedative properties, assessment of sedation, safety and other side-effects[J]. Clin Exp Allergy, 1999, 29(3): 133-142.
  • 6Grattan CE, Wallington TB, Warin RP, et al. A serological mediator in chronic idiopathic urticaria-a clinical, immunological and histological evaluation[J]. Br J Dermatol, 1986, 114(5): 583- 590.
  • 7Grattan CE, Francis DM, Hide M, et al. Detection of circulating histamine releasing autoantibodies with function properties of anti-IgE in chronic urticaria[J]. Clin Exp Allergy, 1991, 21(6): 695-704.
  • 8Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause for histamin release in chronic urticaria[J]. N Engl J Med, 1993, 328(22): 1599-1604.
  • 9Horn MP, Pachlopnik JM, Vogel M, et al. Conditional autoimmunity mediated by human natural anti-Fc (epsilon) Rialpha autoantibodies?[J]. FASEB J, 2001, 15(12): 2268-2274.
  • 10Ferrer M, Nakazama K, Kaplan AP. Complement dependence of histamin release in chronic urticaria[J]. J Allergy Clin Immunol, 1999, 104(1): 169-172.

共引文献202

同被引文献73

引证文献11

二级引证文献50

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部